Search Results - Wustner, Jason

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature

    Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature by Rybinski, Katherine, Imtiyaz, Hongxia Z, Mittica, Barrie, Drozdowski, Brian, Fulmer, James, Furuuchi, Keiji, Fernando, Shawn, Henry, Marianne, Chao, Qimin, Kline, Brad, Albone, Earl, Wustner, Jason, Lin, JianMin, Nicolaides, Nicholas C, Grasso, Luigi, Zhou, Yuhong

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors

    A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors by Diaz, Jr, Luis A, Coughlin, Christina M, Weil, Susan C, Fishel, Jean, Gounder, Mrinal M, Lawrence, Susan, Azad, Nilofer, O'Shannessy, Daniel J, Grasso, Luigi, Wustner, Jason, Ebel, Wolfgang, Carvajal, Richard D

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection

    Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its applic... by Gupta, Anubha, Hussein, Ziad, Hassan, Raffit, Wustner, Jason, Maltzman, Julia D., Wallin, Bruce A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer

    Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer by O'Shannessy, Daniel J., Bendas, Katie, Schweizer, Charles, Wang, Wenquan, Albone, Earl, Somers, Elizabeth B., Weil, Susan, Meredith, Rhonda K., Wustner, Jason, Grasso, Luigi, Landers, Mark, Nicolaides, Nicholas C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer

    Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer by Farrell, Colm, Schweizer, Charles, Wustner, Jason, Weil, Susan, Namiki, Masayuki, Nakano, Tomohisa, Nakai, Kenya, Phillips, Martin D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes

    Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes by Jagodzinski, Paul P., Wustner, Jason, Kmieciak, Dariusz, Wasik, Thomas J., Fertala, Andrzej, Sieron, Aleksander L., Takahashi, Mitsuo, Tsuji, Takashi, Mimura, Tohru, Fung, Michael S., Gorny, Miroslaw K., Kloczewiak, Marek, Kaneko, Yutaro, Kozbor, Danuta

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: